Avitia
Montréal
About Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms. By providing quicker and more precise cancer diagnostics along with tailored treatment options, this approach benefits laboratories, clinicians, and patients alike.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.0M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: avitia.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/avitia-4471 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.